跳至主要内容
临床试验/NCT04599036
NCT04599036进行中(未招募)不适用

Myoelectrolytically Controlled Device in Acute Rehabilitation After Stroke

VA Office of Research and Development2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2020年10月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
3
试验地点
2
主要终点
Changes in arm impairment using Fugl-Meyer assessment (FMA)

研究概览

简要总结

Stroke is a medically relevant problem for the aging population. Individuals with stroke experience a high amount of arm functional deficits despite receiving rehabilitation. Functional deficits can be improved by combining rehabilitation with innovative rehabilitative tools that target the brain mechanisms that guide the recovery early after stroke. This study aims to explore the feasibility of implementing an EMG controlled device in the acute rehabilitation for stroke survivors with severe arm deficit. This study will determine if adding such a technology improve the clinical outcomes for subjects with severe arm impairments beyond the levels achieved by standard care in attempt to increase their chances to independently perform activities of daily living.

详细描述

During the first weeks after the onset of stroke, the injured brain undergoes several neural mechanisms, a process known as neuroplasticity, that intend to reorganize the neural connectivity and repair the damaged tissue around the injury region. Several studies revealed that rehabilitation during this acute period of injury would enhance the functional outcome of the paretic arm presumably by modulating the heightened neuroplastic mechanism. Specifically, it has been suggested that novel interventions that interact with the neuroplastic mechanisms of recovery are particularly needed for stroke survivors whom initial arm impairments are severe.

The rationale of this study is to explore if an EMG controlled device can be added to the acute rehabilitation for stroke subjects with severe arm deficit. The study will also investigate if the application of such a device would lead to an even better enhancement of clinical outcomes compared to standard care. Because of such neurophysiological changes during the acute phase, the study aims to correlate the neurophysiological changes with the enhancement gained as a result of practicing with an EMG controlled device in this population. Thus, test the premise that adding practice with an EMG controlled device to the acute rehabilitation of subjects with severe arm impairments acts as novel rehabilitative tool that interact with the neuroplastic mechanisms of recovery to enhance clinical outcomes for these subjects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Veterans over 18 years of age
  • 2 days to 6 months since the onset of ischemic stroke
  • Adequate range of motion at the elbow, forearm, wrist, and hand to wear the device.
  • Ability to generate volitional, consistent, and detectable EMG signals from the upper arm and forearm sensor sites with wrist in neutral or flexed positions as detected by the Myopro software
  • MAS score 3 for the biceps, triceps, supinators and pronators of the impaired arm
  • Able to read and comprehend the English language
  • Able to follow directions
  • Medically and psychologically stable.
  • Healthy Controls:
  • Over 18 years of age No history of neurological or muscular problems that affect arm function

排除标准

  • Hemorrhagic stroke
  • Previous strokes affecting motor function on the opposite side.
  • Fugl-Meyer score of 2 on the following 3 items:
  • 1) finger mass extension, 2) grasp #1 test, and 3) shoulder flexion 90 - 180 degrees, elbow at 0 degree, and forearm neutral.
  • Shoulder subluxation, pain or dislocation
  • Shoulder passive range of motion < 45 degrees in flexion and abduction
  • Fixed upper limb contractures on the impaired arm and hand
  • Unable to safely support the weight of their arm plus 4 lbs (1.82 kg; the weight of the device) without pain even with arm supported.
  • Skin rash or open wound on impaired arm
  • Involuntary movements of the impaired arm
  • Pacemaker or other implanted devices
  • Metal in the skull
  • Claustrophobia, or inability to operate the MRI patient call button
  • Past history of seizures
  • Family history of medication refractory epilepsy
  • Chronic sleep deprivation, ongoing untreated sleep disorder
  • Pregnancy or pregnancy planning during the study period
  • Currently taking medications or substances that lower the threshold for onset of seizure.
  • Inability to understand English

研究组 & 干预措施

Feasibility

Experimental

To explore if the feasibility of adding an EMG controlled device to the acute rehabilitation for stroke subjects with severe arm deficit.

干预措施: MARK (Device)

结局指标

主要结局

Changes in arm impairment using Fugl-Meyer assessment (FMA)

时间窗: Change from Baseline arm impairment after 6 weeks

Measure of arm impairment. Scores on the FMA may range from 0-66 points, with higher score indicating better performance.

次要结局

  • Changes in arm function using Action Research Arm Test (ARAT)(Change from Baseline arm function after 6 weeks)

研究者

申办方类型
Fed
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验